These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 28298454)

  • 1.
    Karlowsky JA; Lob SH; Kazmierczak KM; Badal RE; Young K; Motyl MR; Sahm DF
    J Clin Microbiol; 2017 Jun; 55(6):1638-1649. PubMed ID: 28298454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
    Çakar A; Akyön Y; Gür D; Karatuna O; Öğünç D; Özhak Baysan B; Çöplü N; Çağatay M; Kılıç A; Baysallar M; Bakıcı Z; Çelik C; Gülay Z; Aydemir Ş; Tünger A; Kılıç H; Erçal BD; Aşçı Toraman Z; Zer Y; Büyüktaş A; Ay S; Aktaş Z; Kayacan Ç; Bayramoğlu G; Aydın F; Dündar D; Hasdemir U; Ayaş R; Yanık K; Günaydın M; Güdücüoğlu H; Parlak M
    Mikrobiyol Bul; 2016 Jan; 50(1):21-33. PubMed ID: 27058326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the modified Hodge test and the Carba NP test for detection of carbapenemases in Enterobacteriaceae isolates].
    Bayramoğlu G; Uluçam G; Gençoğlu Özgür Ç; Kılıç AO; Aydın F
    Mikrobiyol Bul; 2016 Jan; 50(1):1-10. PubMed ID: 27058324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009).
    Lascols C; Hackel M; Marshall SH; Hujer AM; Bouchillon S; Badal R; Hoban D; Bonomo RA
    J Antimicrob Chemother; 2011 Sep; 66(9):1992-7. PubMed ID: 21676902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of carbapenem-resistant
    Yan WJ; Jing N; Wang SM; Xu JH; Yuan YH; Zhang Q; Li AL; Chen LH; Zhang JF; Ma B; Ma Q; Li Y
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33587030
    [No Abstract]   [Full Text] [Related]  

  • 6. Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae in a Tunisian Hospital.
    Ben Helal R; Dziri R; Chedly M; Klibi N; Barguellil F; El Asli MS; Ben Moussa M
    Microb Drug Resist; 2018 Nov; 24(9):1361-1367. PubMed ID: 29596032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
    Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
    Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
    Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
    Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).
    Miltgen G; Bonnin RA; Avril C; Benoit-Cattin T; Martak D; Leclaire A; Traversier N; Roquebert B; Jaffar-Bandjee MC; Lugagne N; Filleul L; Subiros M; de Montera AM; Cholley P; Thouverez M; Dortet L; Bertrand X; Naas T; Hocquet D; Belmonte O
    Int J Antimicrob Agents; 2018 Sep; 52(3):416-420. PubMed ID: 29807164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of Imipenem-Relebactam and Comparator Agents against Genetically Characterized Isolates of Carbapenem-Resistant Enterobacteriaceae.
    Canver MC; Satlin MJ; Westblade LF; Kreiswirth BN; Chen L; Robertson A; Fauntleroy K; La Spina M; Callan K; Jenkins SG
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, southern China.
    Zhou T; Zhang X; Guo M; Ye J; Lu Y; Bao Q; Chi W
    Jpn J Infect Dis; 2013; 66(2):96-102. PubMed ID: 23514904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
    Kim SH; Kim GR; Jeong J; Kim S; Shin JH
    Jpn J Infect Dis; 2020 Nov; 73(6):431-436. PubMed ID: 32475870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissemination of bla
    Magagnin CM; Rozales FP; Antochevis L; Nunes LS; Martins AS; Barth AL; Sampaio JM; Zavascki AP
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1907-1910. PubMed ID: 28555403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified Hodge test using Mueller-Hinton agar supplemented with cloxacillin improves screening for carbapenemase-producing clinical isolates of Enterobacteriaceae.
    Takayama Y; Adachi Y; Nihonyanagi S; Okamoto R
    J Med Microbiol; 2015 Jul; 64(7):774-777. PubMed ID: 25934552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Carbapenemase-Producing Enterobacteriaceae from Patients in Amman, Jordan.
    Aqel AA; Findlay J; Al-Maayteh M; Al-Kaabneh A; Hopkins KL; Alzoubi H; Masalha I; Turton J; Woodford N; Ellington MJ
    Microb Drug Resist; 2018 Oct; 24(8):1121-1127. PubMed ID: 29653473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing New Delhi metallo-β-lactamase-positive Escherichia coli among carbapenem non-susceptible Enterobacteriaceae in Taiwan during 2016 to 2018.
    Huang YS; Tsai WC; Li JJ; Chen PY; Wang JT; Chen YT; Chen FJ; Lauderdale TL; Chang SC
    Sci Rep; 2021 Jan; 11(1):2609. PubMed ID: 33510280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.
    Rimrang B; Chanawong A; Lulitanond A; Wilailuckana C; Charoensri N; Sribenjalux P; Phumsrikaew W; Wonglakorn L; Kerdsin A; Chetchotisakd P
    J Antimicrob Chemother; 2012 Nov; 67(11):2626-30. PubMed ID: 22796889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.
    García-Castillo M; García-Fernández S; Gómez-Gil R; Pitart C; Oviaño M; Gracia-Ahufinger I; Díaz-Regañón J; Tato M; Cantón R;
    Int J Antimicrob Agents; 2018 Mar; 51(3):511-515. PubMed ID: 29371104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
    Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
    Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.